The two companies said the scheme is an opportunity for Healthway shareholders to diversify their investments and gain access to a broader healthcare business including facilities-based business. IHC has a portfolio of medical assets across the PRC, Malaysia, Japan and Australia. The medical assets include hospital and nursing facilities.

If the scheme is approved by shareholders, Healthway will be delisted from Catalist.